Abbott Unit Gets Rival's Anti-Blood Clot Patent Revoked
A Chinese healthcare company has lost its patent over an anti-blood clot heart device after an Abbott unit proved that its sealing and fixing mechanism isn't inventive over an earlier patent,...To view the full article, register now.
Already a subscriber? Click here to view full article